These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Current practices in the validation of aseptic processing--1992. Agalloco J; Akers J J Parenter Sci Technol; 1993; 47 Suppl 1():S1-21. PubMed ID: 8515352 [No Abstract] [Full Text] [Related]
3. Viability-based rapid microbiological methods for sterility testing and the need for identification of contamination. Moldenhauer J PDA J Pharm Sci Technol; 2006; 60(2):81-8. PubMed ID: 16696190 [No Abstract] [Full Text] [Related]
4. The parenteral drug industry: recent findings. Fry EM J Parenter Sci Technol; 1982; 36(2):55-8. PubMed ID: 7077464 [No Abstract] [Full Text] [Related]
5. FDA's role in drug product recalls. Crawford SY Am J Hosp Pharm; 1991 Dec; 48(12):2595-6. PubMed ID: 1814194 [No Abstract] [Full Text] [Related]
6. Application of ISO 9002 and FDA's good manufacturing practices to general chemical manufacturing. Kauffman JM; Weiler ED Qual Assur; 1992 Jun; 1(3):213-6. PubMed ID: 1344676 [TBL] [Abstract][Full Text] [Related]
7. PDA's response to FDA's "Guideline on sterile drug products produced by aseptic processing". Akers JE; Agalloco JP; Carleton FJ; Korczynski MS J Parenter Sci Technol; 1988; 42(4):114-7. PubMed ID: 3183865 [No Abstract] [Full Text] [Related]
8. Aseptic processing contamination case studies and the pharmaceutical quality system. Friedman RL PDA J Pharm Sci Technol; 2005; 59(2):118-26. PubMed ID: 15971544 [TBL] [Abstract][Full Text] [Related]
9. Quality control and good manufacturing practices: safety and efficacy of commercial herbals. Awang DV Food Drug Law J; 1997; 52(3):341-4. PubMed ID: 10343036 [No Abstract] [Full Text] [Related]
10. Drug industry trying to change FDA's slow but sure policy. Demkovich LE Natl J (Wash); 1979 Jul; 11(29):1211-5. PubMed ID: 10242491 [No Abstract] [Full Text] [Related]
11. FDA's regulation of prescription drug labeling: a role for implied preemption. Kendrick LC Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031 [No Abstract] [Full Text] [Related]
12. The FDA's restrictions against prescription drug advertising: more hindrance than help. Lorman AJ Healthspan; 1991 Nov; 8(10):3-7. PubMed ID: 10114942 [No Abstract] [Full Text] [Related]
13. The FDA's accelerated approval process: does the pharmaceutical industry have adequate incentives for self-regulation? Orlando VI Am J Law Med; 1999; 25(4):543-68. PubMed ID: 10629734 [No Abstract] [Full Text] [Related]
17. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate. Dorfman HL; Quinn VM; Brophy EA Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765 [No Abstract] [Full Text] [Related]